wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 101 - 150 of 361.

Physics/Materials Science - Computer Science/Telecom
07.09.2017
High-speed Quantum Memory for Photons
High-speed Quantum Memory for Photons
Physicists from the University of Basel have developed a memory that can store photons. These quantum particles travel at the speed of light and are thus suitable for high-speed data transfer.
Medicine/Pharmacology - Life Sciences
07.09.2017
Novartis presents new analysis demonstrating AMG 334 (erenumab) significantly reduced monthly migraine days in patients who failed previous preventive therapies
Novartis presents new analysis demonstrating AMG 334 (erenumab) significantly reduced monthly migraine days in patients who failed previous preventive therapies AMG 334 (erenumab) delivered consistent reductions in monthly migraine days for patients with chronic migraine and prior treatment failure, a population with significant unmet need   Dedicated cardiovascular safety study reaffirmed placebo-like tolerability of erenumab as seen consisten
Politics - Environment/Sustainable Development
06.09.2017
Mercury: first Minamata Convention conference in Geneva
Bern, 06.09.2017 - The first Conference of the Parties to the Minamata Convention will take place from 24 to 29 September in Geneva.
Medicine/Pharmacology - Life Sciences
06.09.2017
Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer
Roche presents data from global phase III study showing significant clinical benefit of Alecensa (alectinib) in later-line advanced ALK-positive lung cancer ALUR study shows 85% reduction in risk of disease worsening or death versus chemotherapy in patients with advanced ALK-positive NSCLC who had progressed on chemotherapy and crizotinib Roche today announced results from the global phase III ALUR study showing that Alecensa significantly reduc
Physics/Materials Science - Astronomy
06.09.2017
Particle physicists on a quest for
Particle physicists on a quest for "new physics"
EPFL's physicists are moving forward in their efforts to solve the mysteries of the universe. A particle detector made up of 10,000 kilometers of scintillating fiber is under construction and will be added onto CERN's particle accelerator.
Medicine/Pharmacology
05.09.2017
Medicine/Pharmacology - Life Sciences
05.09.2017
Tuberculosis Research Against "Super Resistant Bacteria"
To fall ill from tuberculosis remains a great danger. A research team led by cell biologist Sťbastien Gagneux at the Swiss Tropical and Public Health Institute (Swiss TPH) examines the antibiotic resistance mechanisms of Mycobacterium tuberculosis.
Medicine/Pharmacology
05.09.2017
Medicine/Pharmacology - Life Sciences
05.09.2017
Novartis landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS
Phase III PARADIGMS study in pediatric MS met its primary endpoint, showing a significant reduction in relapses occur with fingolimod versus interferon beta-1a † There is a significant unmet need for safe and effective MS treatments for children and adolescents, for whom there are no specifically approved disease-modifying therapies † Children and adolescents living with MS†face physical and cognitive disability that severely limits their ability to go about daily activities, such as going to†school † † PARADIGMS is a first of its kind study in pediatric MS.
Life Sciences - Environment/Sustainable Development
05.09.2017
Combating Japanese Beetles with Fungi
Zurich-Reckenholz, 05.09.2017 - In June of this year, the Japanese beetle (Popillia japonica) was detected for the first time in Switzerland, in the canton of Ticino. Considered to be a quarantine pest, it is subject to obligatory control. Agroscope researchers are testing whether this quarantine pest can be controlled with fungi that are effective against May and June beetles.
Life Sciences
05.09.2017
First Detailed Decoding of Complex Finger Millet Genome
First Detailed Decoding of Complex Finger Millet Genome
For many poor farmers in India and Africa, finger millet is a major staple food. The crop species is not only a rich source of minerals like calcium, iron, magnesium and zinc, and it contains many vitamins and essential amino acids.
Computer Science/Telecom
04.09.2017
Medicine/Pharmacology - Business/Economics
04.09.2017
Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018
Basel, September 4, 2017 - Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position.
Physics/Materials Science - Life Sciences
04.09.2017
Like a Revolving Door: How Shuttling Proteins Operate Nuclear Pores
Like a Revolving Door: How Shuttling Proteins Operate Nuclear Pores
Nuclear pore complexes are tiny channels where the exchange of substances between the cell nucleus and the cytoplasm takes place. Scientists at the University of Basel report on startling new research that might overturn established models of nuclear transport regulation. Their study published in the Journal of Cell Biology reveals how shuttling proteins known as importins control the function of nuclear pores - as opposed to the view that nuclear pores control the shuttling of importins.
Environment/Sustainable Development - Earth Sciences
04.09.2017
Diverse Landscapes Are More Productive and Adapt better to Climate Change
Diverse Landscapes Are More Productive and Adapt better to Climate Change
The dramatic, worldwide loss of biodiversity is one of today's greatest environmental problems. The loss of species diversity affects important ecosystems on which humans depend. Previous research predominantly addressed short-term effects of biodiversity in small experimental plots planted with few randomly selected plant species.
Business/Economics
03.09.2017
Huge interest in the world of data
Big data, digitalisation, artificial intelligence, Internet of Things - these terms are on everybody's lips these days, but what exactly do they mean?
Environment/Sustainable Development - Event
01.09.2017
Environment/Sustainable Development - Event
01.09.2017
Medicine/Pharmacology - Business/Economics
31.08.2017
Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress
Roche to present new data from its oncology portfolio at the 2017 European Society for Medical Oncology (ESMO) Congress Data from 18 approved and investigational cancer medicines to be presented at ESMO 2017 Results for Zelboraf (vemurafenib) as an adjuvant treatment for BRAF V600 mutation-positive melanoma to feature in the ESMO Presidential Symposium New data from phase III ALEX and ALUR studies provide additional evidence supporting the use o
Physics/Materials Science - Chemistry
31.08.2017
A virtual tour through "move"
Goodbye to fossil fuels, hello to renewables: Empa demonstrates how the mobility of the future can work without fossil energy in its mobility demonstrator "move".
Environment/Sustainable Development - Medicine/Pharmacology
31.08.2017
Life Sciences - Arts and Design
31.08.2017
Artists Target Ibexes
Artists Target Ibexes
The video and sound installations, sculptures, and pictures on display at the exhibition aim to build new bridges between art and the natural sciences.
Pedagogy/Education Science - Medicine/Pharmacology
31.08.2017
Children's sleep quality is related to mothers' insomnia symptoms
Children’s sleep quality is related to mothers’ insomnia symptoms
Children more often sleep poorly if their mothers suffer from insomnia symptoms. This report researchers from the University of Basel and the University of Warwick in the journal Sleep Medicine based on a study with nearly 200 school-aged children and their parents. Sleep plays an essential role for adults' and children's well-being.
Medicine/Pharmacology - Life Sciences
30.08.2017
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice
Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice First-in-clas
Life Sciences - Medicine/Pharmacology
30.08.2017
UZH Life Sciences Fund Invests in First Spin-off
UZH Life Sciences Fund Invests in First Spin-off
CUTISS is a company with a vision: To use personalized skin grafts to heal people all over the world with skin defects, including burn victims.
Administration/Government - Agronomy/Food Science
29.08.2017
Medicine/Pharmacology
29.08.2017
Combination Therapy to Treat Parasitic Worm Infections
Combination Therapy to Treat Parasitic Worm Infections
1.5 billion people worldwide are infected with soil-transmitted helminths, a parasitic worm infection. In the past, only two drugs have been used, increasing the risk of drug resistance. New drugs and combination therapies are thus urgently needed to fight soil-transmitted helminth infections.
Business/Economics - Computer Science/Telecom
29.08.2017
The creative data interpreters
The creative data interpreters
The ETH spin-off SpinningBytes programs software that uses machine learning not only to analyse but also to understand huge amounts of data. It enables customised solutions to be developed for numerous IT problems, and allows new insights to be gained from previously unused data. It all began a few years ago: Mark Cieliebak, Martin Jaggi and Fatih Uzdilli were computer science researchers at ETH and Zurich University of Applied Sciences (ZHAW), and published their technologies in scientific papers.
Microtechnics/Electroengineering - Computer Science/Telecom
29.08.2017
Agronomy/Food Science - Medicine/Pharmacology
29.08.2017
Obese People Lack Cells with Satiety Hormones
Obese People Lack Cells with Satiety Hormones
Individuals with severe overweight have an inhibited sense of satiation - they release fewer satiety hormones than people of normal weight. The reason: the responsible cells in the gastrointestinal tract of obese people are severely reduced. This report Swiss doctors in the journal Scientific Reports.
Mechanical Engineering/Mechanics
28.08.2017
Swissloop finishes in the top 3
Swissloop finishes in the top 3
SpaceX held its second Hyperloop pod competition yesterday in Los Angeles. The Swissloop team including ETH students achieved an outstanding third place finish.
Medicine/Pharmacology - Computer Science/Telecom
28.08.2017
"Medicine is becoming model-driven"
ETH Professor and computer scientist Joachim Buhmann works intensively on healthcare issues. In an interview with ETH News, he explains how computer models will make their way into the world of medicine, and talks about models that are so complicated that humans can no longer process them alone.
Life Sciences
28.08.2017
A drone to rescue fawns
A drone to rescue fawns
Using a thermal camera mounted on a drone, an EPFL student has found a way to spot fawns before the harvester passes through.
Medicine/Pharmacology - Life Sciences
28.08.2017
Chronic Lack of Sleep Increases Risk-Seeking
Chronic Lack of Sleep Increases Risk-Seeking
Young adults have a natural sleep requirement of about 9 hours a day on average, older adults 7.5 hours.
Medicine/Pharmacology
27.08.2017
Novartis Phase III CANTOS study demonstrates that targeting inflammation with ACZ885 reduces cardiovascular risk
Study showed a significant 15% reduction of major adverse cardiovascular events (MACE) in people with a prior heart attack and inflammatory atherosclerosis who were treated with 150mg of ACZ885, in addition to standard of care including lipid-lowering therapy   Effect driven by 24% relative reduction in risk of heart attack; a non-significant 10% reduction in risk of cardiovascular death was observed   Sub-group of study participants whose inf
Medicine/Pharmacology - Life Sciences
27.08.2017
Novartis announces analysis published in The Lancet showing ACZ885 reduced lung cancer mortality by 77% in the CANTOS study with further studies planned
Novartis announces analysis published in The Lancet showing ACZ885 reduced lung cancer mortality by 77% in the CANTOS study with further studies planned Review of blinded, pre-planned oncology safety analyses revealed a 77% reduction in lung cancer mortality and 67% reduction in lung cancer cases in patients treated with 300mg of ACZ885 CANTOS is the first Phase III clinical trial to support a long-established hypothesis from pre-clinical models
Agronomy/Food Science
24.08.2017
Tef benefits from further research funding
Tef benefits from further research funding
Media releases, information for representatives of the media Media Relations (E) Tef is Ethiopia's most important staple food crop.
Environment/Sustainable Development - Sport Sciences
24.08.2017
Sustainable wellness with solar energy
Sustainable wellness with solar energy
There is a growing need in our society for fitness and wellness, which generally incurs environmental costs and swallows up large quantities of energy.
Medicine/Pharmacology - Life Sciences
24.08.2017
Novartis Kisqali (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor
Novartis Kisqali (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor Approval is based on
Medicine/Pharmacology - Business/Economics
24.08.2017
Novartis appoints Bertrand Bodson as Chief Digital Officer
New leader to drive the digital transformation Novartis has embarked upon Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief Digital Officer, reporting to Joseph Jimenez, CEO of Novartis.
Careers/Employment - Medicine/Pharmacology
24.08.2017
Recruiters: Job Hoppers Have Poor Employment Prospects
Recruiters: Job Hoppers Have Poor Employment Prospects
Young people who frequently change jobs or work in positions that are unrelated to their vocational or academic studies are hampering their job chances.
Computer Science/Telecom - Mathematics
23.08.2017
The love of problem-solving
The love of problem-solving
What if you had the chance to complete your own research project at ETH over the summer and to join in discussions about the university‘s future' Two students, Katherine Bancroft and Siqi Liu,
Physics/Materials Science - Mechanical Engineering/Mechanics
23.08.2017
Custom-tailoring better metallic materials
An interview with Helena Van Swygenhoven-Moens Using the large research facilities at PSI, Helena Van Swygenhoven-Moens examines the inner workings of metals.
Administration/Government - Medicine/Pharmacology
23.08.2017
Switzerland once again a full member of partnership-funded EU innovation programmes
Bern, 23.08.2017 - On 23 August, the Federal Council approved the agreements on Switzerland's participation in the Eurostars-2 and the Active and Assisted Living research and development programmes.
Life Sciences - Physics/Materials Science
22.08.2017
Treating arthritis with algae
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating arthritis.
Medicine/Pharmacology - Life Sciences
22.08.2017
New Test for Rare Immunodeficiency
Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency. They reported on their findings in the Journal of Clinical Immunology. Rare diseases are often only diagnosed very late, especially since in many cases, diagnostic tests are not available or are only available in a few laboratories.
Medicine/Pharmacology - Business/Economics
21.08.2017
Novartis and Medicines for Malaria Venture launch patient trial in Africa for KAF156, a novel compound against multidrug-resistant malaria
Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission   KAF156 is first compound fro
Earth Sciences
21.08.2017

 
 
Jobs listed on